Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Nigella Sativa  COVID-19 treatment studies for Nigella Sativa  C19 studies: Nigella Sativa  Nigella Sativa   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases
Shad et al., Clinical and Experimental Pharmacology and Physiology, doi:10.1111/1440-1681.13553 (Review)
Shad et al., The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and.., Clinical and Experimental Pharmacology and Physiology, doi:10.1111/1440-1681.13553 (Review)
Jul 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Review of the pharmacological properties of nigella sativa and thymoquinone and application for a variety of diseases, focusing on recent studies of the anti-inflammatory and antiviral properties that are promising for diseases including COVID-19.
Shad et al., 23 Jul 2021, peer-reviewed, 3 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperNigella SativaAll
Abstract: Received: 15 June 2021 | Revised: 13 July 2021 | Accepted: 14 July 2021 DOI: 10.1111/1440-1681.13553 REVIEW ARTICLE The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases Kaneez Fatima Shad1,2,3,4 | Wissam Soubra1,5,6 | Dennis John Cordato5,7,8 1 University of Technology Sydney, Sydney, Australia 2 Australian Catholic University, Sydney, Australia 3 University of Health Sciences 4 ISRA University Nigella sativa (N. sativa) is an annual flowering plant that has been used as a traditional remedy for many centuries. The seed possesses a large variety of compounds with thymoquinone (TQ) considered its major but not sole bioactive constituent. 5 Ingham Institute for Applied Medical Research 6 Abstract A Health Step Clinic, Sydney, Australia 7 Department of Neurophysiology, Liverpool Hospital, Liverpool, Australia 8 South Western Sydney Clinical School, University of New South Wales, Sydney, Australia Correspondence Kaneez Fatima Shad, School of Life Sciences, University of Technology Sydney, Sydney, Australia. Email: ftmshad@gmail.com, Kaneez. Fatimashad@uts.edu.au Supercritical fluid extraction, geographical location, and oxidative status of N. sativa produces the highest yield of essential oil content including TQ. Thymoquinone is lipophilic, heat and light sensitive with low oral bioavailability and rapid elimination that have significantly inhibited its pharmacological development. Novel developments in nanoparticulate-­based oral administration, nasal spray and transdermal delivery may allow the clinical development of N. sativa and TQ as therapeutic agents. Animal and human studies indicate a potential role of N. sativa seed oil and TQ for a diverse range of disease processes including hypertension, dyslipidaemia, type 2 diabetes mellitus, arthritis, asthma, bacterial and viral infections, neurological and dermatological disorders, as it belongs to the group of pan-­assay interference compounds. This review outlines the pharmacological properties of N. sativa and TQ and their potential wide application for a large variety of human diseases. The paper will focus on recent studies of the anti-­inflammatory and antiviral properties that make N. sativa and TQ promising therapeutic agents targeting contemporary inflammatory and infectious diseases including Covid 19. KEYWORDS Covid 19, oxidative stress, pan-­assay interference compound, SARS-­CoV-­2, supercritical fluid extraction, thymoquinone 1 | been referenced in the Old Testament's Book of Isaiah4 and by the I NTRO D U C TI O N Prophet Muhammad who stated that the black seed is a cure for every disease except death.5 Nigella sativa (N. sativa or black cumin) is an annual flowering plant Nigella sativa seed possesses a large variety of ingredients includ- belonging to the Ranunculaceae (buttercup) family.1-­3 The plant is ing fixed oil, essential or volatile oil, proteins, alkaloids and sapo- native to the eastern Mediterranean, Northern Africa, the Indian nins.1 Oil content of the seed ranges from 30–­4 0%, of which >98% is 1,3 The plant grows 20–­30 cm long, fixed and 0.1–­2% is essential oil.3,6 The major oil components include with a flower containing 5–­10 petals and a fruit comprising a cap- species of triacylglycerol, saturated and unsaturated fatty acids sule of 3–­7 follicles that contain black-­coloured seeds.1 These seeds which may vary according to the extraction method..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit